HLB today announced that the results of an investigator-initiated phase 2 trial of neoadjuvant chemotherapy for gastric cancer patients have been published in the Nature Communications.

Please refer to the following website for further details : Rivoceranib Combination Shows Efficacy in Neoadjuvant Chemotherapy for GC Patients < Health < IT Wellness < 기사본문 - IT Times